Reaction

Injection Site Hypertrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 308 reports · 4 co-occurring drugs

As of the last recalculation, Injection Site Hypertrophy appears in 308 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 402.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Asfotase Alfa50402.5404.5
Interferon Beta-1B828.928.9
Pegvaliase-Pqpz324.924.9
Abaloparatide1023.723.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.